<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">711</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>EARLY DETERIORATION IN QUALITY OF LIFE AND PHYSICAL FUNCTIONING OF MULTIPLE SCLEROSIS PATIENTS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ertekin</surname><given-names>Ozge</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ozakbas</surname><given-names>Serkan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Idiman</surname><given-names>Egemen</given-names></name></contrib></contrib-group><volume>)</volume><issue/><fpage>29</fpage><lpage>38</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Objectives: (1) To examine the associations among ambulatory capacity, physical functioning and quality of life (QOL) in multiple sclerosis patients with different disability levels and compare the results to the healthy controls, and (2) to explain the relationship between QOL, disability status and disease duration. Methods: 112 multiple sclerosis patients and 50 healthy controls were selected for the study. Clinical and demographic data were recorded. Disability status (EDSS), walking ability and capacity (MSWS-12, T25FW), physical functioning (SF-36 /PF-10), QOL (MUSIQOL) and disease severity (MSIS-29) were evaluated. Outcome results of two subgroups with mild and moderate ambulatory impairment were analysed and compared with the control group. Results: There were a statistically significant difference between multiple sclerosis patients with low to moderate disability in MSWS-12, T25FW, SF-36 (PF-10) (p__ampersandsignlt;0.001), and MSIS-29 (p=0.018); additionally in the outcome results for EDDS (p__ampersandsignlt;0.001), MSWS-12 (p__ampersandsignlt;0.001), MSIS-29 (p=0.08) according to the physical functioning classification. Conclusions: The clinical impact of disability severity may contribute to impairments in walking, significantly influencing physical functioning in multiple sclerosis patients. QOL impairment may be emerged regardless of the disability level and disease duration.&#13;
</p></abstract><kwd-group><kwd>Multiple sclerosis</kwd><kwd> Disability</kwd><kwd> Walking</kwd><kwd> Physical functioning</kwd><kwd> Quality of life</kwd></kwd-group></article-meta></front></article>
